Literature DB >> 9855244

Elevated IL-8 levels during sickle cell crisis.

A J Duits1, J B Schnog, L R Lard, A W Saleh, R A Rojer.   

Abstract

The vaso-occlusive process (VOC) in sickle cell disease is of a complex nature. It involves intricate interactions between sickle red blood cells, endothelium and probably also leukocytes. As these interactions are regulated by cytokines, we analyzed the role of the potent neutrophil chemokine IL-8 by measuring serum levels in sickle cell patients during sickle cell crisis. These results were compared to nonsymptomatics and healthy controls. In patients having a vaso-occlusive crisis both HbSS and HbSC patients showed significantly enhanced serum IL-8 levels compared to healthy controls. Several of these patients showed extremely elevated serum IL-8 levels which were independent of the crisis inducing factor. Furthermore, a sickle cell patient with VOC as a complication of rhGM-CSF treatment similarly showed high IL-8 serum levels at crisis onset. Nonsymptomatic sickle cell patients serum IL-8 levels were comparable to healthy controls. These results implicate a role for IL-8 at or during (the initiation of) sickle cell crisis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9855244     DOI: 10.1111/j.1600-0609.1998.tb01092.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  20 in total

Review 1.  Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology.

Authors:  Dachuan Zhang; Chunliang Xu; Deepa Manwani; Paul S Frenette
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

Review 2.  E-selectin ligands as mechanosensitive receptors on neutrophils in health and disease.

Authors:  S D Chase; J L Magnani; S I Simon
Journal:  Ann Biomed Eng       Date:  2012-01-24       Impact factor: 3.934

3.  Immune parameter analysis of children with sickle cell disease on hydroxycarbamide or chronic transfusion therapy.

Authors:  Robert S Nickel; Ifeyinwa Osunkwo; Aneesah Garrett; Jennifer Robertson; David R Archer; Daniel E L Promislow; John T Horan; Jeanne E Hendrickson; Leslie S Kean
Journal:  Br J Haematol       Date:  2015-03-05       Impact factor: 6.998

4.  Neutrophils and leucocyte adhesion molecules in sickle cell retinopathy.

Authors:  M Kunz Mathews; D S McLeod; C Merges; J Cao; G A Lutty
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

5.  Genome-wide association study to identify variants associated with acute severe vaso-occlusive pain in sickle cell anemia.

Authors:  Shruti Chaturvedi; Pallav Bhatnagar; Christopher J Bean; Martin H Steinberg; Jaqueline N Milton; James F Casella; Emily Barron-Casella; Dan E Arking; Michael R DeBaun
Journal:  Blood       Date:  2017-06-05       Impact factor: 22.113

6.  Activation state of alpha4beta1 integrin on sickle red blood cells is linked to the duffy antigen receptor for chemokines (DARC) expression.

Authors:  Marie-Claude Durpès; Marie-Dominique Hardy-Dessources; Wassim El Nemer; Julien Picot; Nathalie Lemonne; Jacques Elion; Monique Decastel
Journal:  J Biol Chem       Date:  2010-11-18       Impact factor: 5.157

7.  Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises.

Authors:  Suba Krishnan; Yamaja Setty; Suhita G Betal; Vaidyula Vijender; Koneti Rao; Carlton Dampier; Marie Stuart
Journal:  Br J Haematol       Date:  2009-12-08       Impact factor: 6.998

8.  Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson.

Authors:  Joshua J Field; Gene Lin; Maureen M Okam; Elaine Majerus; Jeffrey Keefer; Onyinye Onyekwere; Ainsley Ross; Federico Campigotto; Donna Neuberg; Joel Linden; David G Nathan
Journal:  Blood       Date:  2013-02-01       Impact factor: 22.113

Review 9.  Inflammatory targets of therapy in sickle cell disease.

Authors:  Amma Owusu-Ansah; Chibueze A Ihunnah; Aisha L Walker; Solomon F Ofori-Acquah
Journal:  Transl Res       Date:  2015-07-11       Impact factor: 7.012

10.  Placenta growth factor augments endothelin-1 and endothelin-B receptor expression via hypoxia-inducible factor-1 alpha.

Authors:  Nitin Patel; Caryn S Gonsalves; Punam Malik; Vijay K Kalra
Journal:  Blood       Date:  2008-04-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.